MEI HENG
Academic / Other · 2 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia Relapsed/Refractory Acute Myeloid Leukemia(AML) | Phase 1 | 2025-11-18 |
| Completed | Research Development13(RD13)-02 Cell Injection in Patients With Relapsed or Refractory Cluster Of Differentiat Neoplasms, Hematologic Neoplasms, Neoplasms by Site | EARLY_Phase 1 | 2023-03-10 |